Russia's Akrikhin appoints sales/marketing vice president
This article was originally published in Scrip
Sophia Treus has been chosen to fill the new position of vice president for sales and marketing of Akrikhin, the wholly owned subsidiary of Poland's Polpharma and one of Russia's largest pharmaceutical manufacturers. Most recently, she was head of Mylan's representative office in Moscow, and her earlier jobs included managerial positions in Russian subsidiaries of Sandoz (Novartis' generics business) and Egis, Hungary's second-largest pharmaceutical company.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.